发明授权
US07282206B2 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
有权
通过拮抗IL-13和IL-13受体链治疗纤维化
- 专利标题： Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
- 专利标题（中）： 通过拮抗IL-13和IL-13受体链治疗纤维化
-
申请号： US10671034申请日： 2003-09-25
-
公开(公告)号： US07282206B2公开(公告)日： 2007-10-16
- 发明人: Thomas A. Wynn , Monica G. Chiaramonte , Mary Collins , Debra Donaldson , Lori Fitz , Tamlyn Neben , Matthew J. Whitters , Clive Wood
- 申请人： Thomas A. Wynn , Monica G. Chiaramonte , Mary Collins , Debra Donaldson , Lori Fitz , Tamlyn Neben , Matthew J. Whitters , Clive Wood
- 申请人地址： US NJ Madison US DC Washington
- 专利权人： Wyeth,The United States of America as represented by the Department of Health and Human Services
- 当前专利权人： Wyeth,The United States of America as represented by the Department of Health and Human Services
- 当前专利权人地址： US NJ Madison US DC Washington
- 代理机构： Mintz Levin
- 代理商 Ivor R. Elrifi, Esq.; David E. Johnson, Esq.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K39/00
摘要：
Methods are provided for treating or inhibiting the formation of tissue fibrosis using IL-13 antagonists, including without limitation soluble forms of the IL-13 receptor.